NGM Biopharmaceuticals, Inc.
-
Ticker
NGM
-
Industry
Biotechnology More
-
Sector
Healthcare More
- 51-200 Employees
- Based in South San Francisco, California
NGM is a biopharmaceutical company focused on discovering and developing novel therapeutics based on scientific understanding of key biological pathways underlying liver and metabolic diseases, retinal diseases and cancer. They leverage their biology-centric drug discovery approach to uncover novel mechanisms of action and generate proprietary insights that enable them to move rapidly into
…More proof-of-concept studies and deliver potential first-in-class medicines to patients. At NGM, they aspire to operate one of the most productive research and development engines in the biopharmaceutical industry, with multiple programs in clinical development.
REPORT RATINGS
4.8 / 5.0 (130)
NGM Biopharmaceuticals, Inc. reports have an aggregate usefulness score of 4.8 based on 130 reviews.
NGM Biopharmaceuticals, Inc.
Most Recent Annual Report
MOST RECENT
2023 Annual Report, 2022 Form 10K
Older/Archived Annual Reports